Frontlight ResearchEarly access
Trial site
Niepublicznego Zakladu Opieki Zdrowotnej Specjalistyczny Osrodek Internistyczno Diabetologiczny
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes8 trials
- Obesity5 trials
- Chronic kidney disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S5 trials
- AstraZeneca1 trial
- AstraZeneca AB1 trial
- Hoffmann-La Roche1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Not yet recruiting
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Type 2 diabetes2 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026